drugset / Trial / NCT01195688
Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects
RandomizedSingle-groupDouble-blindTreatment
Summary
The primary objective of the current study is to investigate the safety and tolerability of BI 638683 in healthy male volunteers following oral administration of single rising doses
Timeline
- Start
- 2010-09
- Primary completion
- 2010-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 638683 | Unknown | — | Oral |
Indications
No indication recorded.